Literature DB >> 23219261

Clinical experience with adalimumab in anti-TNF-naïve patients with ulcerative colitis.

David Busquets, Xavier Aldeguer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23219261     DOI: 10.1016/j.crohns.2012.11.005

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  1 in total

1.  Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients.

Authors:  Marisa Iborra; Javier Pérez-Gisbert; Marta Maia Bosca-Watts; Alicia López-García; Valle García-Sánchez; Antonio López-Sanromán; Esther Hinojosa; Lucía Márquez; Santiago García-López; María Chaparro; Montserrat Aceituno; Margalida Calafat; Jordi Guardiola; Blanca Belloc; Yolanda Ber; Luis Bujanda; Belén Beltrán; Cristina Rodríguez-Gutiérrez; Jesús Barrio; José Luis Cabriada; Montserrat Rivero; Raquel Camargo; Manuel van Domselaar; Albert Villoria; Hugo Salata Schuterman; David Hervás; Pilar Nos
Journal:  J Gastroenterol       Date:  2016-10-08       Impact factor: 7.527

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.